Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Case report

Page Path
HOME > Article category > Case report
184 Case report
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Case Reports
IBD
Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
Hironobu Takedomi, Kayoko Fukuda, Suma Inoue, Nanae Tsuruoka, Yasuhisa Sakata, Shigehisa Aoki, Motohiro Esaki
Intest Res 2025;23(1):107-111.   Published online August 29, 2024
DOI: https://doi.org/10.5217/ir.2024.00013
AbstractAbstract PDFPubReaderePub
A 47-year-old man with over 10 years’ duration of ulcerative colitis treated by 5-aminosalicylic acid and intermittent topical steroids complained of acute epigastric pain. Esophagogastroduodenoscopy revealed diffuse mucosal edema with patchy redness, multiple erosions and nodularity of the stomach. Bioptic examination revealed marked eosinophilic infiltration, confirming the diagnosis of eosinophilic gastroenteritis. Systemic steroid therapy was initiated, whereas his ulcerative colitis and eosinophilia recurred when tapering the steroid. Addition of azathioprine was ineffective, and we subsequently started vedolizumab for eosinophilic gastroenteritis and ulcerative colitis. The medication effectively improved his abdominal symptoms and esophagogastroduodenoscopy and ileocolonoscopy 1 year later revealed endoscopic improvement of both diseases with histologically decreased level of eosinophilic infiltration. Considering that eosinophils also express α4β7 integrins, vedolizumab can be a possible therapeutic candidate for eosinophilic gastroenteritis as well as ulcerative colitis.
  • 2,334 View
  • 147 Download
Close layer
Miscellaneous
Endoscopic balloon dilations for strictures of rectum, ileocecal valve and duodenum in a patient with X-linked inhibitor of apoptosis deficiency: a case report
Shinsuke Otagiri, Takehiko Katsurada, Kensuke Sakurai, Junichi Sugita, Naoya Sakamoto
Intest Res 2022;20(2):274-277.   Published online February 8, 2022
DOI: https://doi.org/10.5217/ir.2021.00029
AbstractAbstract PDFPubReaderePub
X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency and gastrointestinal (GI) lesions in XIAP deficiency are similar to Crohn’s disease. For patients with Crohn’s disease, endoscopic balloon dilation (EBD) is known to be a standard procedure for intestinal strictures including upper GI tract. However, there are no articles which mention the efficacy of EBDs for the strictures in upper GI tract in patients with XIAP deficiency. Herein, we describe an 18-year-old male with XIAP deficiency in whom EBDs for the rectum, ileocecal valve (ICV), and duodenum were performed. Before hematopoietic stem cell transplantation (HSCT), GI endoscopy revealed strictures of the rectum, ICV and duodenum with active ulcers. Although these ulcers healed after HSCT, the strictures progressed. Therefore, we performed EBDs for the strictures of the rectum, ICV, and duodenum. In contrast studies, we did not find any other strictures in the small intestine. Throughout the patient’s clinical course, no complications of EBD occurred. He started eating after EBDs, but abdominal symptoms did not relapse without any dietary restrictions. Our case suggests that EBD could be an effective and safe procedure for intestinal strictures including upper GI tract after HSCT in patients with XIAP deficiency.
  • 5,154 View
  • 272 Download
Close layer
IBD
Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa, Masatoshi Kawana, Katsutoshi Tokushige
Intest Res 2022;20(1):150-155.   Published online March 12, 2021
DOI: https://doi.org/10.5217/ir.2020.00148
AbstractAbstract PDFPubReaderePub
Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have both inflammatory bowel disease and COVID-19, immunosuppressive therapy is essentially not recommended, and the treatment options are limited. Even in the COVID-19 pandemic, adjuvant adsorptive granulocyte and monocyte apheresis may safely bring ulcerative colitis (UC) into remission by removing activated myeloid cells without the use of immunosuppressive therapy. Our patient was a 25-year-old Japanese male with UC and COVID-19. This is the first case report of the induction of UC remission with granulocyte and monocyte apheresis treatment for active UC associated with COVID-19.

Citations

Citations to this article as recorded by  
  • Phenotypic changes in immune cells induced by granulocyte and monocyte adsorptive apheresis in patients with severe COVID‐19: An ex vivo study
    Ryo Hisamune, Kazuma Yamakawa, Katsuhide Kayano, Noritaka Ushio, Takeshi Wada, Kohei Taniguchi, Akira Takasu
    Acute Medicine & Surgery.2024;[Epub]     CrossRef
  • SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
    Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung
    Intestinal Research.2022; 20(2): 171.     CrossRef
  • SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID
    Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung
    The Korean Journal of Gastroenterology.2021; 78(2): 117.     CrossRef
  • 6,828 View
  • 324 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Miscellaneous
A case of autoimmune enteropathy with CTLA4 haploinsufficiency
Haruka Miyazaki, Namiko Hoshi, Michitaka Kohashi, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Makoto Ooi, Nobuyuki Yamamoto, Suguru Uemura, Noriyuki Nishimura, Kazumoto Iijima, Keisuke Jimbo, Tsubasa Okano, Akihiro Hoshino, Kohsuke Imai, Hirokazu Kanegane, Ichiro Kobayashi, Yuzo Kodama
Intest Res 2022;20(1):144-149.   Published online January 22, 2021
DOI: https://doi.org/10.5217/ir.2020.00041
AbstractAbstract PDFPubReaderePub
Autoimmune enteropathy (AIE) is a rare disease, characterized by intractable diarrhea, villous atrophy of the small intestine, and the presence of circulating anti-enterocyte autoantibodies. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, and mutations in FOXP3, which is a master gene of regulatory T cells (Tregs), are major causes of AIE. Recent studies have demonstrated that mutations in other Treg-associated genes, such as CD25 and CTLA4, show an IPEX-like phenotype. We present the case of a 13-year-old girl with CTLA4 haploinsufficiency, suffering from recurrent immune thrombocytopenic purpura and intractable diarrhea. We detected an autoantibody to the AIE-related 75 kDa antigen (AIE-75), a hallmark of the IPEX syndrome, in her serum. She responded well to a medium dose of prednisolone and a controlled dose of 6-mercaptopurine (6-MP), even after the cessation of prednisolone administration. Serum levels of the soluble interleukin-2 receptor and immunoglobulin G (IgG) were useful in monitoring disease activity during 6-MP therapy. In conclusion, autoimmune-mediated mechanisms, similar to the IPEX syndrome, may be involved in the development of enteropathy in CTLA4 haploinsufficiency. Treatment with 6-MP and monitoring of disease activity using serum levels of soluble interleukin-2 receptor and IgG is suggested for such cases.

Citations

Citations to this article as recorded by  
  • Advances and challenges in diagnosing and managing adult autoimmune enteropathy
    Grigorios Christodoulidis, Sara E Agko, Marina N Kouliou, Konstantinos E Koumarelas, Dimitris Zacharoulis
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Engineering nanoparticle therapeutics for food allergy
    Laila M. Rad, Gabriel Arellano, Joseph R. Podojil, Jessica J. O’Konek, Lonnie D. Shea, Stephen D. Miller
    Journal of Allergy and Clinical Immunology.2024; 153(3): 549.     CrossRef
  • Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders
    Christopher Failing, Jennifer R. Blase, Kelly Walkovich
    Rheumatic Disease Clinics of North America.2023; 49(4): 841.     CrossRef
  • Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab
    Manuel A. Baarslag, Joosje H. Heimovaara, Jessica S.W. Borgers, Koen J. van Aerde, Hans J.P.M. Koenen, Ruben L. Smeets, Pauline L.M. Buitelaar, Dick Pluim, Shoko Vos, Stefanie S.V. Henriet, Jan Willem B. de Groot, Martine van Grotel, Hilde Rosing, Jos H.
    New England Journal of Medicine.2023; 389(19): 1790.     CrossRef
  • Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study
    Akihiro Hoshino, Etsushi Toyofuku, Noriko Mitsuiki, Motoi Yamashita, Keisuke Okamoto, Michio Yamamoto, Kenji Kanda, Genki Yamato, Dai Keino, Yuri Yoshimoto-Suzuki, Junji Kamizono, Yasuhiro Onoe, Takuya Ichimura, Mika Nagao, Masaru Yoshimura, Koji Tsugawa,
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Treg specialization and functions beyond immune suppression
    Jillian L Astarita, Claudia X Dominguez, Corey Tan, Jovanny Guillen, Mariela L Pauli, Rosario Labastida, Jose Valle, Melanie Kleinschek, Jesse Lyons, Ali A Zarrin
    Clinical and Experimental Immunology.2022;[Epub]     CrossRef
  • 8,264 View
  • 415 Download
  • 7 Web of Science
  • 6 Crossref
Close layer
IBD
Pediatric Crohn’s disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature
Eun Sil Kim, Ji Hyung Park, Yon Ho Choe, Mi Jin Kim
Intest Res 2021;19(4):472-477.   Published online October 29, 2020
DOI: https://doi.org/10.5217/ir.2020.00072
AbstractAbstract PDFPubReaderePub
Crohn’s disease (CD) presenting as gastric outlet obstruction is rare but serious clinical presentation of CD causing severe morbidity. However, there have been few case reports concerning this disorder in East Asian children and adolescents. The current case report describes 2 pediatric patients with CD who had had gastric outlet obstruction as an initial symptom of CD. Two pediatric patients developed postprandial vomiting, bloating, and unintentional weight loss. The upper endoscopy result indicated that there was pyloric obstruction with mucosal edema, inflammation and ulcers. The serologic test and colonoscopy results suggested CD. These patients were treated with infliximab, and endoscopic balloon dilation without surgery and showed remarkable improvement in obstructing symptoms with maintaining clinical and biochemical remission. This case report elucidates the benefits of early intervention using infliximab and endoscopic balloon dilation to improve gastric outlet obstruction and achieve baseline recovery in patients with upper gastrointestinal B2 phenotype of CD.

Citations

Citations to this article as recorded by  
  • Upper gastrointestinal tract involvement of Crohn disease: clinical implications in children and adolescents
    Eun Sil Kim, Mi Jin Kim
    Clinical and Experimental Pediatrics.2022; 65(1): 21.     CrossRef
  • 6,205 View
  • 164 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Miscellaneous
Hydroxyurea associated ileocecal valve ulcer: evidence for causality
Thevaraajan Jayaraman, Ruveena Bhavani Rajaram, Gin Gin Gan, Ida Hilmi
Intest Res 2021;19(4):468-471.   Published online December 1, 2020
DOI: https://doi.org/10.5217/ir.2020.00099
AbstractAbstract PDFPubReaderePub
Hydroxyurea is an antimetabolite drug that is commonly used in many hematological disorders. Ulcer formation in the gastrointestinal tract is a rare phenomenon associated with this drug. We report a case of a 73-year-old woman who was found to have an isolated ileocecal valve ulcer while on hydroxyurea 1 g daily for essential thrombocythemia. A comprehensive evaluation ruled out all other causes. The cytoreductive therapy was switched to anagrelide and the endoscopic evaluation 6 months later showed complete healing of the ulcer. However, the hydroxyurea was resumed due to increasing platelet counts and intolerance to dose increments of the anagrelide. Subsequently, the patient was found to have a recurrence of the ulcer. Apart from oral ulcers, there have also been reports of ulcers involving the small bowel and the colon associated with the use of hydroxyurea. The pathophysiology of the non-oral gastrointestinal ulceration in relation to this drug is unclear. Withdrawal of the drug typically leads to complete resolution. Increasing awareness of the rare association between the use of hydroxyurea and nonoral gastrointestinal ulcers is essential for early detection to prevent related complications.

Citations

Citations to this article as recorded by  
  • Esophageal and Ileal Ulcers Caused by Hydroxycarbamide: A Case Report and Literature Review
    Takumi Inaba, Yu Yamamoto, Kaho Hirayama, Takuma Kobayashi, Naoto Izumi, Hirotsugu Sakamoto, Shuji Hatakeyama, Masami Matsumura
    Internal Medicine.2025; 64(6): 845.     CrossRef
  • Hydroxyurea-related ileocecal region ulcers as a rare complication: A case report
    Wen-Jin Yuan, Yi-Juan Zheng, Bing-Rong Zhang, Yi-Jie Lin, You Li, Yan-Yan Qiu, Xue-Ping Yu
    World Journal of Clinical Cases.2025;[Epub]     CrossRef
  • Repairing of recurrent leg ulcer induced by hydroxyurea with posterior tibial artery perforator propeller flap: Case report
    Zheng-Dong Wan, Wu-Zhou Li
    International Journal of Surgery Case Reports.2024; 114: 109049.     CrossRef
  • 7,024 View
  • 186 Download
  • 2 Web of Science
  • 3 Crossref
Close layer
IBD
Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
Jong Won Seo, Eun Soo Kim, Man-Hoon Han, Young Oh Kweon
Intest Res 2021;19(2):247-251.   Published online July 2, 2020
DOI: https://doi.org/10.5217/ir.2020.00016
AbstractAbstract PDFPubReaderePub
Azathioprine is widely used for the treatment of Crohn’s disease (CD). Few cases from Western countries have reported idiopathic non-cirrhotic portal hypertension (NCPH) related to thiopurine therapy in patients with inflammatory bowel disease. Idiopathic NCPH is a rare hepatic condition with intrahepatic portal hypertension but no evidence of cirrhosis or chronic liver disease. Patients with idiopathic NCPH present with symptoms of portal hypertension such as thrombocytopenia, splenomegaly and esophageal varices. We report a case of idiopathic NCPH in a 51-year-old male patient with CD who had been taking azathioprine for 5 years. He was admitted due to esophageal variceal bleeding along with splenomegaly and thrombocytopenia. Evaluation of cirrhosis or chronic liver disease showed normal-range results as estimated by FibroScan evaluation, laboratory examination for autoimmune hepatitis or viral hepatitis, and liver biopsy. This case may suggest the need for careful monitoring for manifestations of portal hypertension in Asian patients with inflammatory bowel disease receiving thiopurine treatment.

Citations

Citations to this article as recorded by  
  • Non-cirrhotic Idiopathic portal hypertension in systemic sclerosis patients: report of one case and a systematic review of previous case reports
    Felipe Souza da Silva, João Victor de Pinho Costa, Carlos Alberto dos Santos Júnior, Érika Emmylaine dos Santos, Ailton José de Castro Júnior, Ana Cecília de Sena Oliveira, Flávia Patrícia Sena Teixeira Santos, Adriana Maria Kakehasi, Débora Cerqueira Cal
    Advances in Rheumatology.2025;[Epub]     CrossRef
  • Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review
    Nicola Pugliese, Lucia Giuli, Elisabetta Mastrorocco, Francesco Santopaolo, Giacomo Marcozzi, Cristina Bezzio, Arianna Dal Buono, Roberto Gabbiadini, Antonio Gasbarrini, Francesca Romana Ponziani, Alessandro Armuzzi, Alessio Aghemo
    Digestive and Liver Disease.2024; 56(6): 964.     CrossRef
  • Non-Cirrhotic Portal Hypertension: an Overview
    Sajid Jalil, Ashwani K. Singal
    Current Hepatology Reports.2024; 23(1): 153.     CrossRef
  • Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
    Hye Kyung Hyun, Hye Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
    Gut and Liver.2024; 18(2): 294.     CrossRef
  • A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
    Michele Fiordaliso, Giuseppe Marincola, Barbara Pala, Raffaella Muraro, Mariangela Mazzone, Maria Carmela Di Marcantonio, Gabriella Mincione
    Diagnostics.2023; 13(20): 3263.     CrossRef
  • Nichtzirrhotische portale Hypertension – Ursachen und praktisches Management
    A. Queck, J. Trebicka
    Der Gastroenterologe.2021; 16(2): 90.     CrossRef
  • 6,404 View
  • 143 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
Infection
Whipple disease mimicking inflammatory bowel disease
Maiko Tatsuki, Takashi Ishige, Yoshiko Igarashi, Reiko Hatori, Akira Hokama, Junko Hirato, Aleixo Muise, Takumi Takizawa, Hirokazu Arakawa
Intest Res 2021;19(1):119-125.   Published online July 3, 2020
DOI: https://doi.org/10.5217/ir.2019.09177
AbstractAbstract PDFPubReaderePub
Whipple disease is a systemic chronic infection caused by Tropheryma whipplei. Although chronic diarrhea is a common gastrointestinal symptom, diagnosis is often difficult because there are no specific endoscopic findings, and the pathogen is not detectable by stool culture. We present a female patient with Whipple disease who developed chronic bloody diarrhea and growth retardation at the age of 4 years. Colonoscopy showed a mildly edematous terminal ileum and marked erythema without vascular patterns throughout the sigmoid colon and rectum. Subsequently, a primary diagnosis of ulcerative colitis was made. Histopathological analysis of the terminal ileum showed the presence of foamy macrophages filled with periodic acidSchiff-positive particles. Polymerase chain reaction using DNA from a terminal ileum biopsy sample amplified a fragment of 16S rRNA from T. whipplei. Antibiotic treatment relieved the patient’s symptoms. There was no evidence of immunodeficiency in the present case. Since Whipple disease worsens after anti-tumor necrosis factor inhibitor therapy, considering this infection in the differential diagnosis may be important in patients with inflammatory bowel disease, especially before initiation of immunotherapy.

Citations

Citations to this article as recorded by  
  • Through the Looking Glass: A Child With Arthralgia, Malaise and Weight Loss
    Aline R. Verhage, Iris D. Nagtegaal, Cathelijne van der Feen, Tom F.W. Wolfs
    Pediatric Infectious Disease Journal.2023; 42(7): 629.     CrossRef
  • Enfermedad de Whipple: revisión sistemática de la literatura
    Ledmar Jovanny Vargas Rodriguez, Jeinny Lucero Ruiz Muñoz, Paola Andrea Bolivar Córdoba, Monica Dayana Romero Cely, Ervirson Jair Cañon Abril, Zulma Marisol Suarez Correa, María Angélica Mendoza Cáceres
    Revista colombiana de Gastroenterología.2023; 38(1): 35.     CrossRef
  • Whipple’s Disease with Colonic Involvement: A Rare Endoscopic Documentation
    Verónica Gamelas, Ines Canha, João Pimentel, Sara Santos, Verónica Borges, Carlos Bernardes
    GE - Portuguese Journal of Gastroenterology.2022; 29(6): 436.     CrossRef
  • Whipple’s disease with normal duodenal histology diagnosed by ileal biopsy using balloon endoscopy
    Hideki Mori, Chiaki Yakabi, Kiwamu Yonahara, Kazunao Hamahiga, Miyu Yoshimura, Masaki Sakihara, Kenji Ishihara, Kinya Azama, Takayuki Chinen, Osamu Zaha
    Clinical Journal of Gastroenterology.2022; 15(4): 702.     CrossRef
  • 9,749 View
  • 194 Download
  • 3 Web of Science
  • 4 Crossref
Close layer
Inflammatory bowel diseases
Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
Yuki Mori, Fumihiko Iwamoto, Yasuaki Ishida, Toru Kuno, Shoji Kobayashi, Takashi Yoshida, Tatsuya Yamaguchi, Tadashi Sato, Makoto Sudo, Daisuke Ichikawa, Nobuyuki Enomoto
Intest Res 2020;18(4):469-475.   Published online May 12, 2020
DOI: https://doi.org/10.5217/ir.2019.09141
AbstractAbstract PDFPubReaderePub
Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furthermore, there is a relationship between MDS in patients with intestinal BD and trisomy 8. Immunosuppressive agents alone are insufficient to control MDS-associated BD, and many of these patients die of infection or hemorrhage. Surgery is considered for intestinal BD patients who are unresponsive to medical treatment or those with bowel complications such as perforation or persistent bleeding. We report a case of intestinal BD associated with MDS and trisomy 8. The patient was unresponsive to oral steroids and immunosuppressive treatment; the patient improved by surgical repair of a bowel perforation. Five years after the surgery, the patient is free of recurrence and not on medication. Our experience suggests that surgery may provide an effective therapeutic option for the treatment of MDS-related BD.

Citations

Citations to this article as recorded by  
  • Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
    Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
    Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
  • Long‐term clinical outcomes of intestinal Behçet's disease: A 30‐year cohort study at a tertiary hospital in South Korea
    Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon
    Journal of Gastroenterology and Hepatology.2023; 38(3): 386.     CrossRef
  • Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet’s disease
    Jihye Park, Hongyul An, Jiwoo Lim, I Seul Park, Mi Hyun Kim, Ji Hyung Kim, Seung Won Kim, Young Il Koh, Eun Young Lee, Jae Hee Cheon
    Arthritis Research & Therapy.2023;[Epub]     CrossRef
  • Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
    Seung Bum Lee, Hee Seung Hong, Chang Kyun Lee, Bo-In Lee, Sol Kim, Seong-Joon Koh, Hosun Yu, Jung-Bin Park, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
    The Korean Journal of Internal Medicine.2023; 38(5): 661.     CrossRef
  • Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea
    Jongwook Yu, Sung Jae Shin, Yune-Jung Park, Hyung Wook Kim, Bo-In Lee, Byong Duk Ye, Geun-Tae Kim, Sung Kook Kim, Joo Sung Kim, Young-Ho Kim, Seonjeong Jeong, Jae Hee Cheon
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Trisomy 8-positive Polycythemia Vera Complicated with Intestinal Behçet's-like Disease: A New Perspective for a Clinical Approach
    Yuki Mori, Fumihiko Iwamoto, Toru Kuno, Shoji Kobayashi, Takashi Yoshida, Tatsuya Yamaguchi, Shinichi Takano, Tetsuo Kondo, Keita Kirito, Nobuyuki Enomoto
    Internal Medicine.2022; 61(11): 1713.     CrossRef
  • Clinical Course of Patients with Intestinal Behçet’s Disease According to Consensus-Based Diagnostic Categories
    Yu Young Joo, Bo-In Lee, Seung-Jun Kim, Han Hee Lee, Jin Su Kim, Jae Myung Park, Young-Seok Cho, Kang Moon Lee, Sang Woo Kim, Hwang Choi, Myung-Gyu Choi
    Gut and Liver.2022; 16(5): 746.     CrossRef
  • 6,177 View
  • 171 Download
  • 7 Web of Science
  • 7 Crossref
Close layer
Inflammatory bowel diseases
Incidental benefits after fecal microbiota transplant for ulcerative colitis
Ramit Mahajan, Vandana Midha, Arshdeep Singh, Varun Mehta, Yogesh Gupta, Kirandeep Kaur, Ritu Sudhakar, Anmol Singh Pannu, Dharmatma Singh, Ajit Sood
Intest Res 2020;18(3):337-340.   Published online April 22, 2020
DOI: https://doi.org/10.5217/ir.2019.00108
AbstractAbstract PDFPubReaderePub
Gut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like metabolic syndrome and functional gastrointestinal disorders. Amongst various therapies targeting gut microbiome, fecal microbiota transplantation (FMT) is becoming a focus in the public media and peer reviewed literature. We have been using FMT for induction of remission in patients with moderate to severe active ulcerative colitis (UC) and also for subsequent maintenance of remission. Four cases reported incidental benefits while being treated with FMT for UC. These included weight loss (n=1), improvement in hair loss (n=1), amelioration of axial arthritis (n=1) and improvement in allergic rhinitis (n=1), thereby suggesting potential clinical applications of FMT in treating extraintestinal diseases associated with gut dysbiosis.

Citations

Citations to this article as recorded by  
  • Fecal microbiota transplantation in allergic diseases
    Ece Tüsüz Önata, Öner Özdemir
    World Journal of Methodology.2025;[Epub]     CrossRef
  • 16S rRNA sequencing-based evaluation of the protective effects of key gut microbiota on inhaled allergen-induced allergic rhinitis
    Yi Tang, Yongchuan She, Danping Chen, Yibo Zhou, Dan Xie, Zhai Liu
    Frontiers in Microbiology.2025;[Epub]     CrossRef
  • α‐Lipoic acid alleviates dextran sulfate sodium salt‐induced ulcerative colitis via modulating the Keap1–Nrf2 signaling pathway and inhibiting ferroptosis
    Peng Jiang, Zongzhen Zhai, Linxian Zhao, Kai Zhang, Liwei Duan
    Journal of the Science of Food and Agriculture.2024; 104(3): 1679.     CrossRef
  • Effects of dietary imbalances of micro- and macronutrients on the ocular microbiome and its implications in dry eye disease
    Madeline Pilkington, Declan Lloyd, Brad Guo, Stephanie L. Watson, Kenneth Gek-Jin Ooi
    Exploration of Medicine.2024; : 127.     CrossRef
  • Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
    Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi
    Intestinal Research.2023; 21(1): 148.     CrossRef
  • Case report: Fecal microbiota transplantation in refractory ankylosing spondylitis
    Lei Wang, Zhimin Wei, Fei Pan, Chuan Song, Lihua Peng, Yunsheng Yang, Feng Huang
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Gut-spine axis: a possible correlation between gut microbiota and spinal degenerative diseases
    Tadatsugu Morimoto, Takaomi Kobayashi, Toshihiko Kakiuchi, Motohiro Esaki, Masatsugu Tsukamoto, Tomohito Yoshihara, Hirohito Hirata, Shoji Yabuki, Masaaki Mawatari
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • Gut microbiota changes in patients with spondyloarthritis: A systematic review
    Lei Wang, Yiwen Wang, Pei Zhang, Chuan Song, Fei Pan, Gang Li, Lihua Peng, Yunsheng Yang, Zhimin Wei, Feng Huang
    Seminars in Arthritis and Rheumatism.2022; 52: 151925.     CrossRef
  • Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases
    Yun Wang, Sheng Zhang, Thomas J. Borody, Faming Zhang
    Chinese Medical Journal.2022;[Epub]     CrossRef
  • Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review
    Xinpei Gu, Qin Lu, Chengcheng Zhang, Zhewei Tang, Liuxi Chu
    Seminars in Liver Disease.2021; 41(04): 495.     CrossRef
  • Intestinal microbiota and inflammatory bowel diseases
    Chang Soo Eun
    Journal of the Korean Medical Association.2021; 64(9): 588.     CrossRef
  • 8,031 View
  • 175 Download
  • 10 Web of Science
  • 11 Crossref
Close layer
Inflammatory bowel diseases
Inflammatory bowel disease and superior mesenteric artery thromboembolism
Steven Nicolaides, Abhinav Vasudevan, Daniel Van Langenberg
Intest Res 2020;18(1):130-133.   Published online September 3, 2019
DOI: https://doi.org/10.5217/ir.2019.00068
AbstractAbstract PDFPubReaderePub
While patients with inflammatory bowel disease are known to be at increased risk of venous thromboembolism, the risk of arterial thrombosis is less well recognized. Here, we describe the case of a middle-aged female with a recent diagnosis of Crohn’s disease who presented to her local emergency department with acute abdominal pain. Subsequent investigations revealed a thrombus in the superior mesenteric artery resulting in multi-organ infarction requiring major intra-abdominal surgery and extensive resection of segments of small and large bowel.

Citations

Citations to this article as recorded by  
  • Etiology and Risk Factors for Splanchnic Vein Thrombosis in Non-Cirrhotic, Non-Neoplastic Patients: A Narrative Review
    Mihaela Hostiuc, Ionut Negoi
    Medicina.2025; 61(5): 933.     CrossRef
  • Navigating the Gut-Cardiac Axis: Understanding Cardiovascular Complications in Inflammatory Bowel Disease
    Tanya Sinha, Zukhruf Zain, Syed Faqeer Hussain Bokhari, Sarosh Waheed, Taufiqa Reza, Anthony Eze-Odurukwe, Mitwa Patel, Mohammed Khaleel I KH Almadhoun , Azlaan Hussain, Ibrahim Reyaz
    Cureus.2024;[Epub]     CrossRef
  • Microscopic Colitis: An Underestimated Disease of Growing Importance
    Kamil Rutkowski, Karina Udrycka, Barbara Włodarczyk, Ewa Małecka-Wojciesko
    Journal of Clinical Medicine.2024; 13(19): 5683.     CrossRef
  • Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study
    Su Young Kim, Yeon Seo Cho, Hyun-Soo Kim, Jung Kuk Lee, Hee Man Kim, Hong Jun Park, Hyunil Kim, Jihoon Kim, Dae Ryong Kang
    Gut and Liver.2022; 16(4): 555.     CrossRef
  • Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview
    Dhir Gala, Taylor Newsome, Nicole Roberson, Soo Min Lee, Marvel Thekkanal, Mili Shah, Vikash Kumar, Praneeth Bandaru, Vijay Gayam
    Diseases.2022; 10(4): 73.     CrossRef
  • 7,339 View
  • 208 Download
  • 4 Web of Science
  • 5 Crossref
Close layer
Colorectal neoplasia
Primary malignant melanoma without melanosis of the colon
Nam Hee Yi, Sang Heon Lee, Sang Heon Lee, Ji Hyun Kim, Sam Ryong Jee, Sang Yong Seol
Intest Res 2019;17(4):561-564.   Published online August 5, 2019
DOI: https://doi.org/10.5217/ir.2019.00020
AbstractAbstract PDFPubReaderePub
Primary malignant melanoma (PMM) of the gastrointestinal tract is rare. Reported cases of PMM of the lower gastrointestinal tract typically describe anal and rectal involvement rather than colonic lesions. This report describes a rare case of a 50-year-old woman with PMM originating in the colon. The patient presented to Inje University Busan Paik Hospital with a 3-day history of blood-tinged stools. She underwent colonoscopy for a diagnosis of hematochezia. The colonoscopic examination revealed a large-sized semi-pedunculated sigmoid colon polyp with a reddish-colored mucosal surface. Endoscopic mucosal resection was performed, and the final histopathological findings were consistent with a diagnosis of malignant melanoma. Systemic work-up was performed for assessment of metastasis and to identify the primary tumor considering the high metastatic rate of gastrointestinal malignant melanoma; however, no other malignant lesion was detected. Thus, she was diagnosed with colonic PMM. She underwent laparoscopic low anterior resection and lymph node dissection and has been recurrence-free for > 2 years.

Citations

Citations to this article as recorded by  
  • Malignant primary melanoma of the colon: a case report
    Claire K Foley, Marybeth S Hughes, Charles T Hehman
    Journal of Surgical Case Reports.2023;[Epub]     CrossRef
  • 6,897 View
  • 184 Download
  • 4 Web of Science
  • 1 Crossref
Close layer
IBD
Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature
Yong-Sung Choi, Jong Kyu Kim, Wan Jung Kim, Mi-Jung Kim
Intest Res 2019;17(2):273-277.   Published online February 12, 2019
DOI: https://doi.org/10.5217/ir.2018.00122
AbstractAbstract PDFPubReaderePub
Although ulcerative colitis (UC) is confined to colonic and rectal mucosa in a continuous fashion, recent studies have also demonstrated the involvement of upper gastrointestinal tract as diagnostic endoscopy becomes more available and technically advanced. The pathogenesis of UC is not well established yet. It might be associated with an inappropriate response of host mucosal immune system to gut microflora. Although continuous and symmetric distribution of mucosal inflammation from rectum to colon is a typical pattern of UC, clinical feature and course of atypically distributed lesions in UC might also help us understand the pathogenesis of UC. Herein, we report a case of duodenal involvement of UC which successfully remitted after infliximab therapy. Endoscopic and pathologic findings before and after administration of anti-tumor necrosis factor suggest that the pathogenesis of upper gastrointestinal involvement of UC may be similar to that of colon involvement.

Citations

Citations to this article as recorded by  
  • A case of relapsed pan-colonic ulcerative colitis accompanied with gastroduodenal lesions immediately after COVID-19
    Katsuya Endo, Tomonori Satoh, Yuki Yoshino, Shiho Kondo, Yoko Kawakami, Daisuke Fukushi, Atsuko Takasu, Takayuki Kogure, Morihisa Hirota, Kennichi Satoh
    Clinical Journal of Gastroenterology.2025; 18(3): 399.     CrossRef
  • Gastroduodenitis Associated with Active Ulcerative Colitis Treated with Infliximab: Different Clinical Course in the Colon and Gastroduodenal Lesions
    Tomoyuki Hayashi, Takeshi Terashima, Masaki Nishitani, Noriaki Orita, Masaki Miyazawa, Akihiro Seki, Hidetoshi Nakagawa, Kouki Nio, Noriho Iida, Shinya Yamada, Hajime Takatori, Tetsuro Shimakami, Taro Yamashita
    Internal Medicine.2024; 63(7): 929.     CrossRef
  • Severe Disease Activity May Predispose Patients to Post-colectomy Duodenitis Associated with Ulcerative Colitis
    Akira Sonoda, Naoki Yoshimura, Minako Sako, Soh Okano, Satoshi Saito, Masakazu Takazoe, Satomi Furukawa, Kinya Okamoto, Tetsuo Yamana, Hisateru Tachimori, Masayuki Fukata
    Internal Medicine.2024; 63(10): 1337.     CrossRef
  • Concurrent occurrence of ulcerative duodenitis and ulcerative colitis displaying unique responses to golimumab and ustekinumab
    Sho Masaki, Hajime Honjo, Masayuki Kurimoto, Natsuki Okai, Yasuo Otsuka, Yasuhiro Masuta, Ken Kamata, Kosuke Minaga, Masatoshi Kudo, Tomohiro Watanabe
    Clinical Journal of Gastroenterology.2024; 17(5): 854.     CrossRef
  • Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls
    Bence Kővári, Rish K. Pai
    Advances in Anatomic Pathology.2022; 29(1): 2.     CrossRef
  • Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review
    Yan Sun, Zhe Zhang, Chang-Qing Zheng, Li-Xuan Sang
    World Journal of Gastroenterology.2021; 27(22): 2963.     CrossRef
  • Clinical characteristics and prognosis of patients with ulcerative colitis that shows rectal sparing at initial diagnosis
    Yong-Sung Choi, Jong-Kyu Kim, Wan-Jung Kim
    World Journal of Gastrointestinal Endoscopy.2021; 13(9): 407.     CrossRef
  • Upper Gastrointestinal Manifestations of Inflammatory Bowel Disease
    Noam Harpaz, Alexandros D. Polydorides
    Surgical Pathology Clinics.2020; 13(3): 413.     CrossRef
  • Two Cases of Ulcerative Colitis-like Gastroduodenitis after Total Proctocolectomy for Intractable Ulcerative Colitis
    Takahiro SHIMOYAMA, Takayuki YAMAMOTO, Yasuhiro INOUE, Satoru UMEGAE
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2019; 80(5): 904.     CrossRef
  • 12,616 View
  • 184 Download
  • 7 Web of Science
  • 9 Crossref
Close layer
IBD
Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn’s disease
Hyeon-A Kim, Hyo-rim Suh, Ben Kang, Byung-Ho Choe, on behalf of Crohn’s and Colitis Association in DaeguGyeongbuk (CCAiD)
Intest Res 2019;17(1):144-148.   Published online October 16, 2018
DOI: https://doi.org/10.5217/ir.2018.00104
AbstractAbstract PDFPubReaderePub
The incidence of inflammatory bowel disease (IBD) is rapidly increasing worldwide. Indigo naturalis is known to have an antiinflammatory effect. Indigo naturalis has been traditionally used in the treatment of IBD in China and Japan. Currently, it is used as a primary or adjunctive drug in patients with ulcerative colitis. There are some reports of the effects of indigo naturalis when used in patients with ulcerative colitis. However, its usage has been associated with adverse events, including liver dysfunction, headache, gastrointestinal disturbance, and pulmonary hypertension. Pancreatitis as an adverse event during treatment using indigo naturalis has not yet been reported. We report a case of recurrent events of pancreatitis that occurred briefly after starting medication with indigo naturalis in a child with severe Crohn’s disease. The pancreatitis improved after indigo naturalis was discontinued in 2 events. This is the first case to report the association between pancreatitis and indigo naturalis in the English literature.

Citations

Citations to this article as recorded by  
  • Selected Use of Complementary and Alternative Medicine (CAM) Agents in IBD
    Monica Dzwonkowski, Janak Bahirwani, Samantha Rollins, Alicia Muratore, Vikram Christian, Yecheskel Schneider
    Current Gastroenterology Reports.2025;[Epub]     CrossRef
  • One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
    Yuichi Matsuno, Takehiro Torisu, Junji Umeno, Hiroki Shibata, Atsushi Hirano, Yuta Fuyuno, Yasuharu Okamoto, Shin Fujioka, Keisuke Kawasaki, Tomohiko Moriyama, Tomohiro Nagasue, Keizo Zeze, Yoichiro Hirakawa, Shinichiro Kawatoko, Yutaka Koga, Yoshinao Oda
    Intestinal Research.2022; 20(2): 260.     CrossRef
  • Pancreatic Disorders in Children with Inflammatory Bowel Disease
    Piotr Jakimiec, Katarzyna Zdanowicz, Kamila Kwiatek-Sredzinska, Aleksandra Filimoniuk, Dariusz Lebensztejn, Urszula Daniluk
    Medicina.2021; 57(5): 473.     CrossRef
  • Accumulation mechanism of indigo and indirubin in Polygonum tinctorium revealed by metabolite and transcriptome analysis
    Wenjing Wang, Yuan Wu, Huihui Xu, Yuan Shang, Yichen Chen, Miaoer Yan, Zhaohui Li, David R. Walt
    Industrial Crops and Products.2019; 141: 111783.     CrossRef
  • 7,806 View
  • 172 Download
  • 4 Web of Science
  • 4 Crossref
Close layer
IBD
5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
Jun Miyoshi, Katsuyoshi Matsuoka, Atsushi Yoshida, Makoto Naganuma, Tadakazu Hisamatsu, Tomoharu Yajima, Nagamu Inoue, Susumu Okamoto, Yasushi Iwao, Haruhiko Ogata, Fumiaki Ueno, Toshifumi Hibi, Takanori Kanai
Intest Res 2018;16(4):635-640.   Published online October 10, 2018
DOI: https://doi.org/10.5217/ir.2018.00015
AbstractAbstract PDFPubReaderePub
Ulcerative colitis (UC) is one of the major clinical phenotypes of inflammatory bowel diseases. Although 5-aminosalicylic acid (5-ASA) is widely used for UC and its efficacy and safety have been demonstrated, a few patients paradoxically develop a severe exacerbation of colitis by 5-ASA administration. It is crucial to know clinical features including endoscopic findings in this condition for making a correct diagnosis and a prompt decision to withdraw the medication. Here, we report case series with UC exacerbated by 5-ASA. Medical records of 8 UC patients experiencing an exacerbation of colitis after induction of 5-ASA that was improved by the withdrawal of 5-ASA but also re-aggravated by dose increase or re-administration of 5-ASA were reviewed. The patients were newly diagnosed with UC, started 5-ASA and developed an exacerbation in approximately 2 to 3 weeks. They did not appear to have systemic allergic reactions. Seven of the 8 patients had a high fever. Three of 5 patients who undertook total colonoscopy showed right-side-dominant colitis. These findings suggest clinical characteristics in this condition. Further assessment of clinical and endoscopic features in more cases is necessary for establishing diagnostic criteria and understanding underlying mechanisms in those cases where 5-ASA aggravates the colitis.

Citations

Citations to this article as recorded by  
  • Secondary loss‐of‐response associated with intolerance to Janus kinase inhibitor in a boy with ulcerative colitis
    Yuka Minoura, Koji Yokoyama, Yuko Okada, Shinya Fukuda, Hideki Kumagai
    Pediatrics International.2025;[Epub]     CrossRef
  • Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies
    Yingying Liu, Ainsley M. Robinson, Xiao Qun Su, Kulmira Nurgali
    Biomolecules.2024; 14(4): 447.     CrossRef
  • Ziziphus jujuba Miller Ethanol Extract Restores Disrupted Intestinal Barrier Function via Tight Junction Recovery and Reduces Inflammation
    Ye Yang, Min Kim, Ho Lee, Won-Yung Lee, Ju-Hye Yang, Hun Kim, Min Shim, Ji Heo, Jae Son, Woo Kim, Gon Kim, Hu-Jang Lee, Young-Woo Kim, Kwang Kim, Kwang Park
    Antioxidants.2024; 13(5): 575.     CrossRef
  • Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
    Hiroshi Matsumoto, Momoyo Sasahira, Tei Tei Go, Shogen Yo, Takehiro Ninomiya, Motoyasu Osawa, Osamu Handa, Eiji Umegami, Ryo Inoue, Akiko Shiotani
    Biomedicines.2024; 12(9): 2125.     CrossRef
  • Phage cocktail inhibits inflammation and protects the integrity of the intestinal barrier in dextran sulfate sodium-induced colitis mice model
    Jiazhen Xu, Ting Liu, Yingchun Shao, Qing Liu, Zongying Zhang, Yang Yuan, Shuangshuang Zhang, Yanhong Wang, Li Sun, Sha Zhou, Minglu Hao, Haoren Xiu, Xiaohui Xing, Dongming Xing
    Microbial Pathogenesis.2024; 197: 107053.     CrossRef
  • Risk factors for intolerance of oral 5‐aminosalicylic acid preparations in pediatric ulcerative colitis
    Naoki Abe, Naomi Iwata, Ryuhei Yasuoka, Daisuke Nishida, Asami Oohara, Haruna Nakaseko, Shiro Sugiura, Shinji Kawabe
    Pediatrics International.2023;[Epub]     CrossRef
  • Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
    Yohei Mikami, Junya Tsunoda, Shohei Suzuki, Ichiro Mizushima, Hiroki Kiyohara, Takanori Kanai
    Digestion.2023; 104(1): 58.     CrossRef
  • APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
    Lauren Sahakian, Ainsley M. Robinson, Linda Sahakian, Rhian Stavely, Mark R. Kelley, Kulmira Nurgali
    Biomolecules.2023; 13(11): 1569.     CrossRef
  • 16,039 View
  • 242 Download
  • 9 Web of Science
  • 8 Crossref
Close layer
Endoscopy
Magnified single-balloon enteroscopy in the diagnosis of intestinal follicular lymphoma: a case series
Kenichiro Takahashi, Shigeki Bamba, Masahiro Kawahara, Atsushi Nishida, Osamu Inatomi, Masaya Sasaki, Tomoyuki Tsujikawa, Ryoji Kushima, Mitsushige Sugimoto, Katsuyuki Kitoh, Akira Andoh
Intest Res 2018;16(4):628-634.   Published online October 10, 2018
DOI: https://doi.org/10.5217/ir.2018.00003
AbstractAbstract PDFSupplementary MaterialPubReaderePub
The objective of this study was to evaluate the magnified endoscopic findings in the diagnosis of follicular lymphoma in the small intestine in comparison with those of intestinal follicular lymphoma and lymphangiectasia. Four patients with follicular lymphoma and 3 with lymphangiectasia in the small intestine were retrospectively analyzed. A prototype magnifying singleballoon enteroscope was used. The findings of the intestinal follicular lymphoma and lymphangiectasia were retrospectively analyzed to determine the magnified endoscopic findings of follicular lymphoma in the small intestine. Opaque white granules were observed in 3 of the 4 patients with follicular lymphoma. Magnified narrow-band imaging (NBI) of the opaque white granules showed stretched microvessels, which had a diminutive tree-like appearance. The remaining patient had no opaque white granules and only displayed whitish villi. Magnified NBI observation of the whitish villi revealed the absence of marginal villus epithelium, which was confirmed by histology. The magnified NBI enteroscopy revealed the diminutive tree-like appearance on the opaque white granules and the absence of marginal villus epithelium of the whitish villi in intestinal follicular lymphoma. These findings may be useful in diagnosing follicular lymphoma.

Citations

Citations to this article as recorded by  
  • A case of intestinal T‐cell lymphoma, not otherwise specified, that showed characteristic findings by magnified endoscopy combined with narrow‐band imaging
    Yuki Hirose, Satoshi Saito, Takanori Nishiguchi, Dai Yamazaki, Tsubasa Tateishi, Yuuichi Saito, Yukiko Komeno, Makoto Kodama, Shiho Iwamoto, Masayuki Fukata, Minako Sako
    DEN Open.2024;[Epub]     CrossRef
  • Discordance Rate and Risk Factor of Other Diagnostic Modalities for Small Bowel Tumors Detected by Device-Assisted Enteroscopy: A Korean Association for the Study of Intestinal Disease (KASID) Multicenter Study
    Jihye Park, Jin Su Kim, Joo Hye Song, Kwangwoo Nam, Seong-Eun Kim, Eui Sun Jeong, Jae Hyun Kim, Seong Ran Jeon
    Gut and Liver.2024; 18(4): 686.     CrossRef
  • Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma
    Akihiko Sumioka, Shiro Oka, Issei Hirata, Sumio Iio, Akiyoshi Tsuboi, Hidehiko Takigawa, Ryo Yuge, Yuji Urabe, Kazuki Boda, Tomohiko Kohno, Hideharu Okanobu, Yasuhiko Kitadai, Koji Arihiro, Shinji Tanaka
    Journal of Gastroenterology.2022; 57(9): 667.     CrossRef
  • 9,322 View
  • 185 Download
  • 4 Web of Science
  • 3 Crossref
Close layer
IBD
Enteric infections complicating ulcerative colitis
Dejan Micic, Ayal Hirsch, Namrata Setia, David T. Rubin
Intest Res 2018;16(3):489-493.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.489
AbstractAbstract PDFPubReaderePub

Enteric infections have previously been postulated to play a role in the pathogenesis of inflammatory bowel disease (IBD), however, little evidence exists in the etiologic role of specific enteric infections in the development of IBD. When encountered in the setting of IBD, enteric infections pose a clinical challenge in management given the competing treatment strategies for infectious conditions and autoimmune disorders. Here we present the case of a young male with enteric infections complicating a new diagnosis of IBD. Our patient's initial clinical presentation included diagnoses of Klebsiella oxytoca isolation and Clostridium difficile infection. Directed therapies to include withdrawal of antibiotics and fecal microbiota transplantation were performed without resolution of clinical symptoms. Given persistence of symptoms and active colitis, the patient was diagnosed with ulcerative colitis (UC), requiring treatments directed at severe UC to include cyclosporine therapy. The finding of multiple enteric infections in a newly presenting patient with IBD is an unexpected finding that has treatment implications.

Citations

Citations to this article as recorded by  
  • Echinacea purpurea Polysaccharide Ameliorates Dextran Sulfate Sodium-Induced Colitis by Restoring the Intestinal Microbiota and Inhibiting the TLR4-NF-κB Axis
    Fan-Hao Wei, Wen-Yin Xie, Pei-Sen Zhao, Wei Gao, Fei Gao
    Nutrients.2024; 16(9): 1305.     CrossRef
  • Inflammatory bowel disease complicated with rare pathogen infection
    Jia-Heng Fang, Guo-Xiong Li
    World Chinese Journal of Digestology.2023; 31(1): 8.     CrossRef
  • Usefulness of Stool Multiplex Polymerase Chain Reaction Assays in Patients with Acute Diarrhea
    Seo Hyun Kim, You Sun Kim, Seung Hyuk Kim, Won Eui Yoon, Hee Jun Myung, Jeong Seop Moon, Dong Hee Whang
    The Korean Journal of Gastroenterology.2022; 79(3): 118.     CrossRef
  • Animal unit hygienic conditions influence mouse intestinal microbiota and contribute to T-cell-mediated colitis
    Mariana Cázares-Olivera, Dominika Miroszewska, Lili Hu, Jacek Kowalski, Ulla-Marjut Jaakkola, Seppo Salminen, Bin Li, Emrah Yatkin, Zhi Chen
    Experimental Biology and Medicine.2022; 247(19): 1752.     CrossRef
  • Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction
    Zhongmei Sun, Wenjing Pei, Yi Guo, Zhibin Wang, Rui Shi, Xiaowei Chen, Xingjie Zhao, Chen Chen, Jiali Liu, Xiang Tan, Wenjing Yuan, Tangyou Mao
    Evidence-Based Complementary and Alternative Medicine.2019; 2019: 1.     CrossRef
  • Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease
    Shu-Ling Wang, Bo-Zong Shao, Sheng-Bing Zhao, Xin Chang, Pei Wang, Chao-Yu Miao, Zhao-Shen Li, Yu Bai
    Cell Death & Disease.2019;[Epub]     CrossRef
  • 7,308 View
  • 101 Download
  • 5 Web of Science
  • 6 Crossref
Close layer
IBD
Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus
Tomoyoshi Shibuya, Keiichi Haga, Masato Kamei, Koki Okahara, Shoko Ito, Masahito Takahashi, Osamu Nomura, Takashi Murakami, Masae Makino, Tomohiro Kodani, Dai Ishikawa, Naoto Sakamoto, Taro Osada, Tatsuo Ogihara, Sumio Watanabe, Akihito Nagahara
Intest Res 2018;16(3):484-488.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.484
AbstractAbstract PDFPubReaderePub

Ulcerative colitis (UC) is 1 of the 2 major phenotypes of chronic inflammatory bowel disease (IBD), which afflicts millions of individuals throughout the world with debilitating symptoms that impair function and quality of life. Further, IBD often affects women during childbearing age. Indeed, UC activity frequently increases during pregnancy, and the medications used to induce remission may adversely affect the health of the mother and the unborn child. We report successful induction of a remission in a UC case who experienced a flare-up in the first trimester of pregnancy. Upon relapse, she was treated with steroids and adsorptive granulomonocytapheresis (GMA) with the Adacolumn plus tacrolimus. This combination therapy induced a stable remission that was maintained during her entire pregnancy. She gave birth to a healthy child at 36 weeks of pregnancy with no maternal or fetal complications. Our experience indicates that GMA, as a non-drug therapeutic intervention with a favorable safety profile, plus tacrolimus might be a relevant treatment option for patients with active IBD during pregnancy. A future study of a large cohort of pregnant patients should strengthen our findings.

Citations

Citations to this article as recorded by  
  • Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited
    Filippo Vernia, Angelo Viscido, Giovanni Latella
    Journal of Clinical Apheresis.2023; 38(6): 746.     CrossRef
  • Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
    Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Salim Surani
    World Journal of Clinical Cases.2022; 10(21): 7195.     CrossRef
  • Reproductive Health in IBD Patients
    Sanket Patel, Haleh Vaziri
    Current Treatment Options in Gastroenterology.2021; 19(2): 237.     CrossRef
  • Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
    Xiu-Li Chen, Jing-Wei Mao, Ying-De Wang
    World Journal of Gastrointestinal Pathophysiology.2020; 11(3): 43.     CrossRef
  • Women’s Health and Ulcerative Colitis
    Kindra Clark-Snustad, Madalina Butnariu, Anita Afzali
    Gastroenterology Clinics of North America.2020; 49(4): 769.     CrossRef
  • 10,748 View
  • 111 Download
  • 3 Web of Science
  • 5 Crossref
Close layer
IBD
A case of ulcerative colitis presenting with cerebral venous thrombosis
Junghwan Lee, Sung Wook Hwang, Jinhee Lee, Kyung Hwa Jung, Ha Il Kim, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
Intest Res 2018;16(2):306-311.   Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.306
AbstractAbstract PDFPubReaderePub

Patients with inflammatory bowel disease (IBD) have been reported to have an increased risk of thromboembolism. Cerebral venous thrombosis (CVT) is a rare but serious extraintestinal manifestation of IBD. Due to its highly variable manifestation and low incidence, CVT is not usually readily recognized by physicians. Herein, we report a case of a 35-year-old male presenting with CVT associated with ulcerative colitis (UC). The patient was admitted with chief complaints of bloody diarrhea that had started 3 days prior. Sigmoidoscopy showed hyperemic and edematous mucosa, friability, and shallow ulcers from the sigmoid colon to the rectum suggestive of IBD. Three days later, the patient started complaining of a headache, and gradually developed a decreased level of consciousness. Magnetic resonance imaging of the brain revealed CVT with hemorrhagic infarctions. An angiogram was obtained to evaluate the extent of CVT, and anticoagulation therapy was initiated with intravenous heparin. During hospitalization, he was diagnosed with UC and treated with 5-aminosalicylic acid. After discharge, the patient was recovered without neurological deficit, and remission of UC was also obtained. The presence of headache or acute worsening of neurological status in a patient with IBD should alert the health professionals about the possibility of CVT.

Citations

Citations to this article as recorded by  
  • Digit Necrosis After Hand Surgery in Pregnancy: A Case Report
    Natalia Ziolkowski, Jana Dengler, Cory S Goldberg
    Plastic Surgery Case Studies.2021;[Epub]     CrossRef
  • Cerebral venous thrombosis as presenting manifestation of inflammatory bowel disease (IBD)
    Katie Stamp, Alison Pattinson, Paul Maliakal, Thekootu Nandakumar, Shaji Sebastian
    GastroHep.2019; 1(1): 45.     CrossRef
  • 8,058 View
  • 103 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
IBD
Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis
Hyun Il Seo, Hyun-Ju Lee, Koon Hee Han
Intest Res 2018;16(1):155-157.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.155
AbstractAbstract PDFPubReaderePub

Pyoderma gangrenosum (PG), an ulcerating skin condition, is rare in patients with ulcerative colitis (UC). We report a case of successful treatment of PG in a patient with UC using hyperbaric oxygen therapy (HBOT). The patient had UC that was in remission following treatment with mesalazine and azathioprine therapy. After visiting an orthopedic clinic, the patient opted for treatment with antibiotics and daily dressing of the ulcerative skin lesions, while azathioprine was discontinued. However, the lesions did not improve. Two months later, the patient visited a dermatologist who diagnosed the lesions as PG, and he was admitted to our unit. Surgical debridement and HBOT were performed by a plastic surgeon in the emergency department. After 3 months of HBOT and topical treatment, the patient's PG completely resolved. His UC was still in remission with mesalazine alone. HBOT may be an effective and safe alternative treatment for PG associated with UC, particularly in patients in whom anti-tumor necrosis factor agents are unnecessary.

Citations

Citations to this article as recorded by  
  • The new insights of hyperbaric oxygen therapy: focus on inflammatory bowel disease
    Leilei Chen, Yan Wang, Huihui Zhou, Yi Liang, Fengqin Zhu, Guangxi Zhou
    Precision Clinical Medicine.2024;[Epub]     CrossRef
  • Emerging Indications for Hyperbaric Oxygen Treatment: Registry Cohort Study
    Hideaki L Tanaka, Judy R Rees, Ziyin Zhang, Judy A Ptak, Pamela M Hannigan, Elaine M Silverman, Janet L Peacock, Jay C Buckey
    Interactive Journal of Medical Research.2024; 13: e53821.     CrossRef
  • EFICÁCIA DA OXIGENOTERAPIA HIPERBÁRICA NO TRATAMENTO DE PIODERMA GANGRENOSO
    Ana Júllia Almeida Ferreira, Natally Macedo Torrente, Pedro Paulo Custódio Martinez Sacchi, Poliana Pezzotto
    RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218.2024; 5(9): e595755.     CrossRef
  • Treatment of Pyoderma Gangrenosum With Mycophenolate and Hyperbaric Oxygen Therapy: A Case Report and Literature Review
    Subo Dey, Nirali Sanghavi, Amy Wasserman, Kausik Kar
    Cureus.2023;[Epub]     CrossRef
  • Efficacy and safety evaluation of hyperbaric oxygen therapy for patients with ulcerative colitis
    Wei Wang, Ying He, Dou Wen, Shangshang Jiang, Xiaodong Zhao
    Medicine.2021; 100(1): e23966.     CrossRef
  • Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn’s Disease: An Observational Study
    Marley R. Feitosa, Rogério S. Parra, Vanessa F. Machado, Gustavo N. Vilar, Jussara C. Aquino, José J. R. Rocha, Paulo G. Kotze, Omar Féres, Chiara Ricci
    Gastroenterology Research and Practice.2021; 2021: 1.     CrossRef
  • The role of hyperbaric oxygen therapy in inflammatory bowel disease
    Xin Wu, Tian-Yu Liang, Zhong Wang, Gang Chen
    Medical Gas Research.2021; 11(2): 66.     CrossRef
  • Giant pyoderma gangrenosum in a patient with ulcerative colitis
    Ruixian Niu, Jiangtao Zheng, Dongmei Ding, Weian Kuang, Fengyan Lu, Xunguo Yin
    Medicine.2020; 99(6): e18795.     CrossRef
  • Development of an International, Multicenter, Hyperbaric Oxygen Treatment Registry and Research Consortium: Protocol for Outcome Data Collection and Analysis
    Nicole P Harlan, Judy A Ptak, Judy R Rees, Devin R Cowan, Abigail M Fellows, Judith A Kertis, Pamela M Hannigan, Janet L Peacock, Jay C Buckey
    JMIR Research Protocols.2020; 9(8): e18857.     CrossRef
  • Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy
    Giorgia Guaitoli, Federico Piacentini, Claudia Omarini, Alessia Andreotti, Enza Palma, Simona Papi, Chiara De Pietri, Andrea Conti, Stefano Cascinu, Giovanni Tazzioli
    Breast Cancer.2019; 26(4): 520.     CrossRef
  • Atypical wounds. Best clinical practice and challenges
    Kirsi Isoherranen, Julie Jordan O'Brien, Judith Barker, Joachim Dissemond, Jürg Hafner, Gregor B. E. Jemec, Jivko Kamarachev, Severin Läuchli, Elena Conde Montero, Stephan Nobbe, Cord Sunderkötter, Mar Llamas Velasco
    Journal of Wound Care.2019; 28(Sup6): S1.     CrossRef
  • Pyoderma Gangrenosum: What Do We Know Now?
    Fatima McKenzie, Megan Arthur, Alex G. Ortega-Loayza
    Current Dermatology Reports.2018; 7(3): 147.     CrossRef
  • Pyoderma gangrenosum – an interdisciplinary approach to the disease
    Aleksandra Kapuśniak, Aleksandra Czachor, Grażyna Wąsik
    Medical Science Pulse.2018; 12(4): 61.     CrossRef
  • 8,615 View
  • 69 Download
  • 12 Web of Science
  • 13 Crossref
Close layer
IBD
Duodenal amyloidosis secondary to ulcerative colitis
Seung Woon Park, Sam Ryong Jee, Ji Hyun Kim, Sang Heon Lee, Jin Won Hwang, Ji Geon Jang, Dong Woo Lee, Sang Yong Seol
Intest Res 2018;16(1):151-154.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.151
AbstractAbstract PDFPubReaderePub

Amyloidosis is defined as the extracellular deposition of non-branching fibrils composed of a variety of serum-protein precursors. Secondary amyloidosis is associated with several chronic inflammatory conditions, such as rheumatologic or intestinal diseases, familial Mediterranean fever, or chronic infectious diseases, such as tuberculosis. Although the association of amyloidosis with inflammatory bowel disease is known, amyloidosis secondary to ulcerative colitis (UC) is rare. A 36-year-old male patient with a 15-year history of UC presented with nausea, vomiting, and abdominal pain. He had been treated with infliximab for 6 years. At the time of admission, he had been undergoing treatment with mesalazine and adalimumab since the preceding 5 months. Esophagogastroduodenoscopy showed mucosal erythema, edema, and erosions with geographic ulcers at the 2nd and 3rd portions of the duodenum. Duodenal amyloidosis was diagnosed using polarized light microscopy and Congo red stain. Monoclonal gammopathy was not detected in serum and urine tests, while the serum free light chain assay result was not specific. An increase in plasma cells in the bone marrow was not found. Secondary amyloidosis due to UC was suspected. The symptoms were resolved after glucocorticoid therapy.

Citations

Citations to this article as recorded by  
  • Gastrointestinal amyloidosis in a 50‐year‐old patient with miliary tuberculosis: A case report
    Sameer Abdul Rauf, Hussain Haider Shah, Rahul Khatri, Mansoor Ul Haq, Tirth Dave, Javaria Parwez Ali, Syed Khizar Ali
    Clinical Case Reports.2024;[Epub]     CrossRef
  • Therapeutic effects of biological treatments on AA amyloidosis associated with inflammatory bowel disease: a case report and literature review
    Marouf Alhalabi, Kamal Alaa Eddin, Ahmad Abbas
    European Journal of Gastroenterology & Hepatology.2023; 35(11): 1298.     CrossRef
  • Rheumatoid arthritis: Extra-articular manifestations and comorbidities
    Fabiana Assunta Figus, Matteo Piga, Irene Azzolin, Rebecca McConnell, Annamaria Iagnocco
    Autoimmunity Reviews.2021; 20(4): 102776.     CrossRef
  • Specific Clinical and Morphological Characteristics of Amyloidosis of the Stomach and Duodenum
    Z. V. Gioeva, L. M. Mikhaleva
    Journal of Anatomy and Histopathology.2019; 8(1): 39.     CrossRef
  • Morphological and Immunohistochemical Characteristics of Experimental Mandibular Fractures Healing Process
    A. A. Matchin, A. A. Stadnikov, E. V. Nosov, S. Kh. Kiriakidi
    Journal of Anatomy and Histopathology.2019; 8(1): 44.     CrossRef
  • Secondary, AA, Amyloidosis
    Riccardo Papa, Helen J. Lachmann
    Rheumatic Disease Clinics of North America.2018; 44(4): 585.     CrossRef
  • 7,781 View
  • 76 Download
  • 5 Web of Science
  • 6 Crossref
Close layer
IBD
A case of pemphigus vulgaris associated with ulcerative colitis
Joo Wan Seo, Jongha Park, Jin Lee, Mi Young Kim, Hyun Ju Choi, Heui Jeong Jeong, Ji Woon Lee, So Young Jung, Woo Kyeong Kim
Intest Res 2018;16(1):147-150.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.147
AbstractAbstract PDFPubReaderePub

Pemphigus vulgaris is an autoimmune bullous disorder characterized by the production of autoantibodies against the intercellular space of the epithelium. It has rarely been reported in association with inflammatory bowel disease. Ulcerative colitis is one of the forms of inflammatory bowel disease. A 62-year-old woman who had been treated for ulcerative colitis for 16 years developed pruritic bullae on the skin of her face and body. Histological findings and direct immunofluorescence examination of the skin showed pemphigus vulgaris. She was treated with systemic steroids, mesalazine, and azathioprine. Her cutaneous lesions have remained in remission and her ulcerative colitis has remained well-controlled. The relationship between pemphigus vulgaris and ulcerative colitis is unclear. An autoimmune response has been suspected in the pathogenesis of ulcerative colitis. Pemphigus vulgaris is also associated with an autoimmune mechanism. To our knowledge, this is the first case of ulcerative colitis associated with pemphigus vulgaris reported in Korea. The association may be causal.

Citations

Citations to this article as recorded by  
  • Autoimmune pemphigus: difficulties in diagnosis and the molecular mechanisms underlying the disease
    Olga Simionescu, Sorin Ioan Tudorache
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Persistent Scattered Pustules: Vesiculopustular IgA Pemphigus Arising in a Patient With Ulcerative Colitis
    Melissa M. Warne, Matthew F. Helm, Andrew Gaddi, Raminder Grover
    The American Journal of Dermatopathology.2023; 45(5): 350.     CrossRef
  • Cell-Matrix Interactions Contribute to Barrier Function in Human Colon Organoids
    James Varani, Shannon D. McClintock, Muhammad N. Aslam
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview
    Kyla Pagani, Danitza Lukac, Aashni Bhukhan, Jean S. McGee
    American Journal of Clinical Dermatology.2022; 23(4): 481.     CrossRef
  • Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review
    Heng L. Tham, Keith E. Linder, Thierry Olivry
    BMC Veterinary Research.2020;[Epub]     CrossRef
  • 7,826 View
  • 58 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
IBD
Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
Kosaku Nanki, Shinta Mizuno, Katsuyoshi Matsuoka, Keiko Ono, Shinya Sugimoto, Hiroki Kiyohara, Mari Arai, Moeko Nakashima, Kozue Takeshita, Keiichiro Saigusa, Mitsutoshi Senoh, Tadashi Fukuda, Makoto Naganuma, Haru Kato, Wataru Suda, Masahira Hattori, Takanori Kanai
Intest Res 2018;16(1):142-146.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.142
AbstractAbstract PDFPubReaderePub

Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

Citations

Citations to this article as recorded by  
  • Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized IBD Patients and the Role of Fecal Microbiota Transplantation: A Retrospective Cohort Study
    Puo‐Hsien Le, Chyi‐Liang Chen, Chia‐Jung Kuo, Pai‐Jui Yeh, Chien‐Chang Chen, Yi‐Ching Chen, Cheng‐Tang Chiu, Hao‐Tsai Cheng, Yung‐Kuan Tsou, Yu‐Bin Pan, Cheng‐Hsun Chiu
    The Kaohsiung Journal of Medical Sciences.2025;[Epub]     CrossRef
  • Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Clostridioides difficile Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study
    Jing-Han Chen, Cheng-Hsun Chiu, Chien-Chang Chen, Yi-Ching Chen, Pai-Jui Yeh, Chia-Jung Kuo, Cheng-Tang Chiu, Hao-Tsai Cheng, Yu-Bin Pan, Puo-Hsien Le
    Biomedicines.2024; 12(7): 1396.     CrossRef
  • Case report: Fecal microbiota transplant for Clostridium difficile infection in a pregnant patient with acute severe ulcerative colitis
    Hanyu Wang, Feihong Deng, Min Luo, Xuehong Wang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
    Loris Riccardo Lopetuso, Sara Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca Ianiro, Luca Masucci, Maria Abreu, Iris Dotan, Samuel Paul Costello, Ailsa Hart, Tariq H Iqbal, Sudarshan Paramsothy, Maurizio San
    Gut.2023; 72(9): 1642.     CrossRef
  • Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome
    Kazuyoshi Gotoh, Yoshihiko Sakaguchi, Haru Kato, Hayato Osaki, Yasutaka Jodai, Mitsutaka Wakuda, Akira Také, Shunji Hayashi, Eri Morita, Takehiko Sugie, Yoichiro Ito, Naoki Ohmiya
    Anaerobe.2022; 73: 102502.     CrossRef
  • Management of Clostridioides difficile infection in patients with inflammatory bowel disease
    Sahil Khanna
    Intestinal Research.2021; 19(3): 265.     CrossRef
  • Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
    Xiao Yan Guo, Xin Juan Liu, Jian Yu Hao
    Journal of Digestive Diseases.2020; 21(3): 147.     CrossRef
  • RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
    Jung Hoon Song, You Sun Kim
    Gut and Liver.2019; 13(1): 16.     CrossRef
  • Current Status of Clostridium Difficile Infection
    Akira Andoh, Shigeki Bamba
    Nippon Daicho Komonbyo Gakkai Zasshi.2018; 71(10): 456.     CrossRef
  • 9,068 View
  • 87 Download
  • 8 Web of Science
  • 9 Crossref
Close layer
A case of celiac disease with neurologic manifestations misdiagnosed as amyotrophic lateral sclerosis
Hyoju Ham, Bo-In Lee, Hyun Jin Oh, Se Hwan Park, Jin Su Kim, Jae Myung Park, Young Seok Cho, Myung-Gyu Choi
Intest Res 2017;15(4):540-542.   Published online October 23, 2017
DOI: https://doi.org/10.5217/ir.2017.15.4.540
AbstractAbstract PDFPubReaderePub

Celiac disease (CD) is an immune-mediated enteropathy and is a rare disease in Asia, including in Korea. However, the ingestion of wheat products, which can act as a precipitating factor of CD, has increased rapidly. CD is a common cause of malabsorption, but many patients can present with various atypical manifestations as first presented symptoms, including anemia, osteopenia, infertility, and neurological symptoms. Thus, making a diagnosis is challenging. We report a case of CD that mimicked amyotrophic lateral sclerosis (ALS). The patient was a sexagenary man with a history of progressive motor weakness for 2 years. He was highly suspected as having ALS. During evaluation of his neurological symptoms, esophagogastroduodenoscopy (EGD) was performed because he had experienced loose stools and weight loss for the previous 7 months. On EGD, the duodenal mucosa appeared smooth. A biopsy revealed severe lymphoplasma cell infiltration with flattened villi. His serum endomysial antibody (immunoglobulin A) titer was 1:160 (reference, <1:40). Finally, he was diagnosed as having CD, and a gluten-free diet was immediately begun. At a 4-month follow-up, his weight and the quality of his stool had improved gradually, and the neurological manifestations had not progressed.

Citations

Citations to this article as recorded by  
  • Prevalence of genetic markers of celiac disease in different populations
    G. N. Yankina, E. I. Kondratieva, E. V. Loshkova
    Archives of Pediatrics and Pediatric Surgery.2025; 2(3): 27.     CrossRef
  • The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis
    Mohamed J. Saadh, Shahad Mohammed Dhiaa, Pooja Bansal, Hasan Khalid Dabis, Ashu Katyal, Vivek Saraswat, Azher Abdulmutaleb Ibrahim, Radi Usama Kadem, Mohammed Ubaid
    Current Behavioral Neuroscience Reports.2025;[Epub]     CrossRef
  • Celiac disease - a pluripathological model in pediatric practice
    Vasile Valeriu Lupu, Maria Oana Sasaran, Elena Jechel, Iuliana Magdalena Starcea, Ileana Ioniuc, Adriana Mocanu, Solange Tamara Rosu, Valentin Munteanu, Alin Horatiu Nedelcu, Ciprian Danielescu, Delia Lidia Salaru, Anton Knieling, Ancuta Lupu
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • The presence and clinical significance of autoantibodies in amyotrophic lateral sclerosis: a narrative review
    Shen Liu, Ye Hong, Bian-Rong Wang, Zi-Qiao Wei, Hong-Dong Zhao, Teng Jiang, Ying-Dong Zhang, Jian-Quan Shi
    Neurological Sciences.2024; 45(9): 4133.     CrossRef
  • Celiac Disease Genetics, Pathogenesis, and Standard Therapy for Japanese Patients
    Tasuku Tamai, Kenji Ihara
    International Journal of Molecular Sciences.2023; 24(3): 2075.     CrossRef
  • A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men
    Sarah Martin, Carolina Battistini, Jun Sun
    Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
  • Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
    Sonalika Bhalla, Sidharth Mehan, Andleeb Khan, Muneeb U. Rehman
    Neuroscience & Biobehavioral Reviews.2022; 142: 104896.     CrossRef
  • Target Metabolites to Slow Down Progression of Amyotrophic Lateral Sclerosis in Mice
    Destiny Ogbu, Yongguo Zhang, Katerina Claud, Yinglin Xia, Jun Sun
    Metabolites.2022; 12(12): 1253.     CrossRef
  • Total serum immunoglobulin A in ALS
    Jesse Crayle, Mai Elmallah, John Sleasman, Richard Bedlack
    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.2021; 22(1-2): 61.     CrossRef
  • Underutilization of diagnostic assays for celiac disease in Korea
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee
    Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
  • Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis
    Yongguo Zhang, Destiny Ogbu, Shari Garrett, Yinglin Xia, Jun Sun
    Gut Microbes.2021;[Epub]     CrossRef
  • Premalignant Lesions of the Small Intestine
    Su Hwan Kim, Ji Won Kim
    Journal of Digestive Cancer Reports.2021; 9(2): 60.     CrossRef
  • The effects of diet and sex in amyotrophic lateral sclerosis
    J.A. Pape, J.H. Grose
    Revue Neurologique.2020; 176(5): 301.     CrossRef
  • “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities
    Daniel Harrison, Paul Mehta, Michael A. van Es, Elijah Stommel, Vivian E. Drory, Beatrice Nefussy, Leonard H. van den Berg, Jesse Crayle, Richard Bedlack
    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.2018; 19(7-8): 495.     CrossRef
  • 8,385 View
  • 77 Download
  • 12 Web of Science
  • 14 Crossref
Close layer
Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab
Shinji Okabayashi, Taku Kobayashi, Tomohisa Sujino, Ryo Ozaki, Satoko Umeda, Takahiko Toyonaga, Eiko Saito, Masaru Nakano, Maria Carla Tablante, Shojiroh Morinaga, Toshifumi Hibi
Intest Res 2017;15(4):535-539.   Published online October 23, 2017
DOI: https://doi.org/10.5217/ir.2017.15.4.535
AbstractAbstract PDFPubReaderePub

Extracolonic involvement of the gastrointestinal tract is extremely uncommon in ulcerative colitis (UC) and rarely found in the upper gastrointestinal tract or in postoperative cases since it typically responds to steroids. Here we report a case of UC complicated by extensive ileal inflammation that was refractory to steroids. A 20-year-old man was diagnosed with UC of typical pancolitis without ileal involvement and started treatment with pH-dependent mesalazine and oral prednisolone. Although his symptoms transiently resolved, the condition flared when the steroid dose was tapered down. Computed tomography revealed marked thickening of the ileal wall, and capsule endoscopy and balloon-assisted enteroscopy found diffuse mucosal inflammation with ulcers in the ileum. On the contrary, the inflammation in the colon and rectum was improving. Since the response to the second steroid course was inadequate, treatment with adalimumab and 6-mercaptopurine was initiated and finally achieved clinical and endoscopic remission. The investigation of small intestinal lesions is necessary in patients with UC whose clinical deterioration cannot be explained by colonic lesions.

Citations

Citations to this article as recorded by  
  • A case of relapsed pan-colonic ulcerative colitis accompanied with gastroduodenal lesions immediately after COVID-19
    Katsuya Endo, Tomonori Satoh, Yuki Yoshino, Shiho Kondo, Yoko Kawakami, Daisuke Fukushi, Atsuko Takasu, Takayuki Kogure, Morihisa Hirota, Kennichi Satoh
    Clinical Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Clinical Features and Therapeutic Outcomes of Post-colectomy Enteritis with Ulcerative Colitis
    Yuki Horio, Motoi Uchino, Kazutoshi Hori, Kurando Kusunoki, Tomohiro Minagawa, Ryuichi Kuwahara, Kozo Kataoka, Naohito Beppu, Masataka Ikeda, Hiroki Ikeuchi
    Journal of the Anus, Rectum and Colon.2021; 5(4): 405.     CrossRef
  • 8,601 View
  • 68 Download
  • 3 Web of Science
  • 2 Crossref
Close layer
Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide
Jina Yeo, Hyun Sun Woo, Sang Min Lee, Yoon Jae Kim, Kwang An Kwon, Dong Kyun Park, Jung Ho Kim, Kyoung Oh Kim, Jun-Won Chung
Intest Res 2017;15(4):529-534.   Published online October 23, 2017
DOI: https://doi.org/10.5217/ir.2017.15.4.529
AbstractAbstract PDFPubReaderePub

Oral 5-aminosalicylic acid agents (mesalazine and sulfasalazine) and azathioprine are the mainstays of treatment for inflammatory bowel disease. Reports of pulmonary toxicity induced by oral 5-aminosalicylic acid agents or azathioprine in patients with inflammatory bowel disease are very rare; to date, only 38 cases have been reported worldwide. We, herein, report a case involving a 26-year-old man who was diagnosed with eosinophilic pneumonia after using mesalazine and azathioprine for the treatment of Crohn's disease and recovered after treatment. We also found that the fraction of exhaled nitric oxide level was elevated in this patient. After treatment, the fraction of exhaled nitric oxide level decreased and the symptoms improved. The present case shows that fraction of exhaled nitric oxide is related to the disease activity and treatment effectiveness of druginduced eosinophilic pneumonia.

Citations

Citations to this article as recorded by  
  • Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system
    Ashwin Kamath
    Scientific Reports.2025;[Epub]     CrossRef
  • Qualitative and quantitative study of intermolecular weak interactions for aminosalicylic acid isomers by terahertz spectroscopy
    Yuan Tang, Zhi Li, Shan Tu, Yulai She, Yongying Gan
    International Journal of Quantum Chemistry.2022;[Epub]     CrossRef
  • Spontaneous resolution of focal eosinophilic myositis of the adductor pollicis complicated by lung lesions
    Sayuri Yamashita, Hidenaga Kawasumi, Makiko Kimura, Mutsuto Tateishi
    Modern Rheumatology Case Reports.2020; 4(1): 106.     CrossRef
  • lncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn's disease
    Na Li, Rui-Hua Shi
    World Journal of Gastroenterology.2020; 26(5): 478.     CrossRef
  • Expression alteration of long non-coding RNAs and their target genes in the intestinal mucosa of patients with Crohn’s disease
    Na Li, Ruihua Shi
    Clinica Chimica Acta.2019; 494: 14.     CrossRef
  • Mesalazin-induced eosinophilic pneumonia in a 15-year-old boy with ulcerative colitis
    G. N. Yankinа, L. V. Gorlenko, E. V. Loshkova, E. I. Kondratyeva, E. Yu. Tuteva, A. A. Terenteva, V. A. Zhelev, E. V. Mikhalev, T. A. Shemyakinа, T. S. Krivonogova, N. A. Ryzhakova, E. V. Romanova
    Bulletin of Siberian Medicine.2019; 18(3): 245.     CrossRef
  • Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBD
    Ewa Dudzińska, Magdalena Gryzinska, Katarzyna Ognik, Paulina Gil-Kulik, Janusz Kocki, Vladimir Jakovljevic
    Oxidative Medicine and Cellular Longevity.2018;[Epub]     CrossRef
  • 7,204 View
  • 71 Download
  • 5 Web of Science
  • 7 Crossref
Close layer
Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
Way-Seah Lee, Najib Azmi, Ruey-Terng Ng, Sik-Yong Ong, Sasheela Sri La Ponnampalavanar, Sanjiv Mahadeva, Ida Hilmi
Intest Res 2017;15(4):524-528.   Published online October 23, 2017
DOI: https://doi.org/10.5217/ir.2017.15.4.524
AbstractAbstract PDFPubReaderePub

Anti-tumor necrosis factor (anti-TNF) is highly effective in inflammatory bowel disease (IBD); however, it is associated with an increased risk of infections, particularly in older adults. We reviewed 349 patients with IBD, who were observed over a 12-month period, 74 of whom had received anti-TNF therapy (71 patients were aged <60 years and 3 were aged ≥60 years). All the 3 older patients developed serious infectious complications after receiving anti-TNFs, although all of them were also on concomitant immunosuppressive therapy. One patient developed disseminated tuberculosis, another patient developed cholera diarrhea followed by nosocomial pneumonia, while the third patient developed multiple opportunistic infections (Pneumocystis pneumonia, cryptococcal septicemia and meningitis, Klebsiella septicemia). All 3 patients died within 1 year from the onset of the infection(s). We recommend that anti-TNF, especially when combined with other immunosuppressive therapy, should be used with extreme caution in older adult patients with IBD.

Citations

Citations to this article as recorded by  
  • Infection toxicity assessment of tumor necrosis factor α inhibitors in the treatment of IBD: a real-world study based on the US food and drug administration adverse events reporting system (FAERS)
    Qian Cheng, Zeyu Yao, Xuan Shi, Shupeng Zou, Yazheng Zhao, Mengling Ouyang, Minghui Sun
    Expert Opinion on Drug Safety.2025; : 1.     CrossRef
  • RATE OF INFECTION (TUBERCULOSIS) IN BRAZILIANS IBD PRIVATE PATIENTS: FOLLOW-UP 15 YEARS
    Didia B CURY, Liana C B CURY, Ana C MICHELETTI, Rogério A OLIVEIRA, José J S GONÇALVES
    Arquivos de Gastroenterologia.2024;[Epub]     CrossRef
  • Cryptococcosis Associated With Biologic Therapy: A Narrative Review
    Xin Li, Olivier Paccoud, Koon-Ho Chan, Kwok-Yung Yuen, Romain Manchon, Fanny Lanternier, Monica A Slavin, Frank L van de Veerdonk, Tihana Bicanic, Olivier Lortholary
    Open Forum Infectious Diseases.2024;[Epub]     CrossRef
  • Inflammatory bowel disease complicated with rare pathogen infection
    Jia-Heng Fang, Guo-Xiong Li
    World Chinese Journal of Digestology.2023; 31(1): 8.     CrossRef
  • Pulmonary cryptococcosis after immunomodulator treatment in patients with Crohn’s disease: Three case reports
    Yan-Fei Fang, Xiang-Han Cao, Ling-Ya Yao, Qian Cao
    World Journal of Gastroenterology.2023; 29(4): 758.     CrossRef
  • Systemic lupus erythematosus complicated by Crohn’s disease with rectovaginal fistula
    Heng Yeh, Ren-Chin Wu, Wen-Sy Tsai, Chia-Jung Kuo, Ming-Yao Su, Cheng-Tang Chiu, Puo-Hsien Le
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Systematic review with meta‐analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease
    Daniele Piovani, Silvio Danese, Laurent Peyrin‐Biroulet, Georgios K. Nikolopoulos, Stefanos Bonovas
    Alimentary Pharmacology & Therapeutics.2020; 51(9): 820.     CrossRef
  • Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis
    Nienke Z. Borren, Ashwin N. Ananthakrishnan
    Clinical Gastroenterology and Hepatology.2019; 17(9): 1736.     CrossRef
  • Improving Quality in the Care of Patients with Inflammatory Bowel Diseases
    Matthew D Egberg, Ajay S Gulati, Ziad F Gellad, Gil Y Melmed, Michael D Kappelman
    Inflammatory Bowel Diseases.2018; 24(8): 1660.     CrossRef
  • 6,191 View
  • 92 Download
  • 7 Web of Science
  • 9 Crossref
Close layer
Behçet's disease with multiple splenic abscesses in a child
Kyung In Lim, Dong Hwa Yang, Eell Ryoo
Intest Res 2017;15(3):422-428.   Published online June 12, 2017
DOI: https://doi.org/10.5217/ir.2017.15.3.422
AbstractAbstract PDFPubReaderePub

We report the case of a 5-year-old male patient with multiple aseptic splenic abscesses associated with Behçet's disease. The patient visited Gachon University Gil Hospital with fever, abdominal pain, and acute watery and bloody diarrhea, and reported a 2-year history of chronic abdominal pain and intermittent watery diarrhea. He was treated with antibiotics at a local clinic for fever and cervical lymph node swelling. Additionally, he had recurrent stomatitis. A colonoscopy showed multiple well-demarcated ulcerations throughout the colon, and abdominal computed tomography showed multiple splenic abscesses. Pathergy and HLA-B51 tests were positive. Investigations did not reveal any infectious organisms in the aspirate obtained via ultrasound-guided fine needle aspiration. After steroid treatment, all symptoms and multiple aseptic splenic abscesses resolved. However, oral ulcers, genital ulcers, and abdominal pain recurred after tapering the steroids. Infliximab treatment improved the patient's symptoms. However, 5 months after the treatment, the symptoms recurred. The treatment was changed to include adalimumab. Subsequently, the patient's symptoms resolved and colonoscopic findings improved. No recurrence was noted after 3 months of follow-up.

Citations

Citations to this article as recorded by  
  • Aseptic Abscess of the Spleen as an Antecedent Manifestation of Behçet’s Disease
    Mohamed Jazeer, Diroji Antony, Mayurathan Pakkiyaretnam
    Cureus.2023;[Epub]     CrossRef
  • Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data
    Ezgi Deniz Batu, Seher Sener, Veysel Cam, Nuray Aktay Ayaz, Seza Ozen
    BioDrugs.2023; 37(6): 813.     CrossRef
  • Case report: Aseptic splenic abscesses in childhood-onset systemic lupus erythematosus
    Shobashenee Sritharan, Peter Sie-Teck Lau, Kamilah Manan, Anand Mohan
    Frontiers in Pediatrics.2023;[Epub]     CrossRef
  • Successful management of a case of intestinal Behçet’s disease with a splenic abscess by intensified immunosuppressive therapy without splenectomy
    Noriko Sato, Fumiya Yamaide, Ryohei Shibata, Taiji Nakano, Akiko Yamaide, Takeshi Saito, Naoki Shimojo
    Modern Rheumatology Case Reports.2022; 6(2): 266.     CrossRef
  • Adalimumab in the treatment of pediatric Behçet’s disease: case-based review
    Dimitri Poddighe, Zaure Mukusheva, Kaisar Dauyey, Maikesh Assylbekova
    Rheumatology International.2019; 39(6): 1107.     CrossRef
  • 8,113 View
  • 64 Download
  • 6 Web of Science
  • 5 Crossref
Close layer
Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
Harshal Surendra Mandavdhare, Vishal Sharma, Kaushal K Prasad, Amit Kumar, Manish Rathi, Surinder S Rana
Intest Res 2017;15(3):419-421.   Published online June 12, 2017
DOI: https://doi.org/10.5217/ir.2017.15.3.419
AbstractAbstract PDFPubReaderePub

Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the class of “sartans” remains to be clarified. A 45-year-old woman with chronic kidney disease along with hypothyroidism and hypertension presented with chronic diarrhea and significant weight loss. Endoscopy of the upper gastrointestinal tract showed scalloping and grooving of the duodenum, and histopathological examination showed subtotal villous atrophy. She was on telmisartan for hypertension, which was discontinued. Subsequently, diarrhea ameliorated dramatically, and she regained weight. To our knowledge, this is the first study to report telmisartan-associated sprue-like enteropathy. Further, we have reviewed the cases of patients with sprue-like enteropathy caused by valsartan, irbesartan, and eprosartan.

Citations

Citations to this article as recorded by  
  • Olmesartan induced gastritis and enteropathy
    Ankur Gupta, Priyanka Jain, Latika Gupta
    Indian Journal of Gastroenterology.2024; 43(3): 684.     CrossRef
  • Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
    Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, Stiliano Maimaris, Giovanni Arpa, Federico Biagi, David S. Sanders
    Alimentary Pharmacology & Therapeutics.2024; 59(4): 432.     CrossRef
  • Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report
    N Van Horebeek, R Croes, A Vonck, E Colpaert
    Acta Gastro Enterologica Belgica.2023; 86(1): 95.     CrossRef
  • A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
    Seo Yeon Yoo, Jihun Kim, Kee Wook Jung
    Journal of Neurogastroenterology and Motility.2022; 28(2): 327.     CrossRef
  • The histological spectrum of ARB‐induced gastritis
    Tanner Storozuk, Ian Brown, Stephen Lagana, Maria Westerhoff, Namrata Setia, John Hart, Lindsay Alpert
    Histopathology.2022; 81(5): 653.     CrossRef
  • Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan
    Peter Malfertheiner, Chiara Formigoni
    GastroHep.2021; 3(2): 88.     CrossRef
  • Telmisartan-induced sprue-like enteropathy: a case report
    Natalia Alzueta, Amaya Echeverría, Lorea Sanz, Carmen Fontela, Teresa Acín, Lidia Montenegro, Javier Garjón
    European Journal of Hospital Pharmacy.2020; 27(1): 49.     CrossRef
  • Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture
    Francesco Abbruzzi, Ilaria Loconte, Sonia Carparelli, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi
    Current Drug Safety.2020; 15(1): 65.     CrossRef
  • Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
    A. Sadki, M. Le Besnerais, F. Héron, I. Marie
    La Revue de Médecine Interne.2019; 40(2): 112.     CrossRef
  • A simple treatment for a potentially life-threatening cause of malabsorption
    Mattia Bonzi, Elisa M. Fiorelli, Gaia Montanelli, Ludovico Furlan, Monica Solbiati
    Internal and Emergency Medicine.2019; 14(6): 967.     CrossRef
  • Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
    Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
    Gastroenterology Report.2019; 7(3): 162.     CrossRef
  • Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
    René R. Wenzel, Christian Datz
    Wiener klinische Wochenschrift.2019; 131(19-20): 493.     CrossRef
  • Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
    Peter Malfertheiner, Claudio Ripellino, Nazarena Cataldo
    Pharmacoepidemiology and Drug Safety.2018; 27(6): 581.     CrossRef
  • 6,765 View
  • 91 Download
  • 14 Web of Science
  • 13 Crossref
Close layer
Coexistence of ulcerative colitis and Sjögren's syndrome in a patient with Takayasu's arteritis and Hashimoto's thyroiditis
Hyun Woo Park, Hyun Seok Lee, Sejin Hwang, Han Sol Lee, Han-Ik Bae, Ghilsuk Yoon
Intest Res 2017;15(2):255-259.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.255
AbstractAbstract PDFPubReaderePub

A 31-year-old woman with a 15-year history of Takayasu's arteritis (TA) and a 13-year history of Hashimoto's thyroiditis presented with hematochezia. She received a diagnosis of Sjögren's syndrome at 1 month before her visit to Kyungpook National University Medical Center. Her colonoscopic findings were compatible with a diagnosis of ulcerative colitis (UC). She was treated with oral mesalazine, and her hematochezia symptoms subsequently disappeared. The coexistence of UC and TA has been reported; however, reports on the coexistence of UC and Sjögren's syndrome, or of UC and Hashimoto's thyroiditis are rare. Although the precise etiologies of these diseases are unknown, their presence together suggests that they may have a common pathophysiologic background. Furthermore, in patients with autoimmune or vascular diseases, including TA, systemic manifestations should be assessed with consideration of inflammatory bowel diseases including UC in the presence of gastrointestinal symptoms such as diarrhea and hematochezia.

Citations

Citations to this article as recorded by  
  • The association of common autoimmune diseases with autoimmune thyroiditis: a two-sample Mendelian randomization study
    Kaiyuan Zhang, Ziyue Luo, Xinchang Wang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • A case of seronegative primary Sjögren’s syndrome complicated by Takayasu arteritis in a Japanese girl
    Shingo Yamanishi, Yujiro Tanabe, Makoto Watanabe, Hidehiko Narazaki, Toru Igarashi, Ryuji Fukazawa, Mitsuaki Isobe, Yasuhiko Itoh
    Modern Rheumatology Case Reports.2023; 7(1): 148.     CrossRef
  • Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy
    C. Betterle, J. Furmaniak, C. Sabbadin, C. Scaroni, F. Presotto
    Journal of Endocrinological Investigation.2023; 46(4): 643.     CrossRef
  • Takayasu arteritis associated with autoimmune/inflammatory syndrome induced by adjuvants: a case-based review
    Desislava Simeonova, Tsvetoslav Georgiev, Tanya Shivacheva
    Rheumatology International.2023; 43(5): 975.     CrossRef
  • Co-existing ulcerative colitis and takayasu arteritis: A case-based review
    KaranRajgopal Kalani, AnujAchyut Ban, Sumeet Singla
    Indian Journal of Rheumatology.2022; 17(4): 416.     CrossRef
  • Takayasu’s Arteritis in a Patient With Preexisting Autoimmune Disease
    Robert Holton-Burke, Sarah Laurenzano, Susan Phillips, Laurie Bernard Stover, Suhas Radhakrishna, Manaswitha Khare
    Clinical Pediatrics.2021; 60(4-5): 210.     CrossRef
  • 8,104 View
  • 58 Download
  • 6 Web of Science
  • 6 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP